
pmid: 16880085
Catastrophic APS is a potentially life-threatening condition with a high mortality, which requires high clinical awareness. New mechanisms for its production can only be explored if samples are obtained, stored, and dis-patched to investigation sites in Europe (Barcelona), the United States (Atlanta), and Japan (Sapporo). Details will be posted and made available on the International Registry Web Site in 2006. It is essential that the condition be diagnosed early and treated aggressively. The combination of high doses of iv heparin, iv steroids plus repeated doses of iv gammaglobulins or plasma exchange is the treatment of choice in patients with this severe condition. Additionally, preventive measures in patients with APS may be effective if the development of the catastrophic APS is to be avoided.
Early Diagnosis, Plasma Exchange, Heparin, Multiple Organ Failure, Anticoagulants, Humans, Immunoglobulins, Intravenous, Thrombosis, Antiphospholipid Syndrome, Catastrophic Illness, Combined Modality Therapy, Glucocorticoids
Early Diagnosis, Plasma Exchange, Heparin, Multiple Organ Failure, Anticoagulants, Humans, Immunoglobulins, Intravenous, Thrombosis, Antiphospholipid Syndrome, Catastrophic Illness, Combined Modality Therapy, Glucocorticoids
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 22 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
